IMUX: immunic-therapeutics.com Kompaniya qiymatining sof foydaga nisbati
Immunic, Inc. (IMUX) hozirda foyda olmagan bosqichda bo'lib, yuqori tadqiqot xarajatlari umumiy rentabellikni cheklamoqda va joriy ko'rsatkich -1.00 ni tashkil etmoqda. Ushbu bozor narxi grafigi aktivning dinamikasini aks ettiradi, bunda kompaniya immunoterapiya segmentida ustunlik qilish uchun sklerozga qarshi selektiv agentlar portfelini kengaytirmoqda. Rivojlanish trayektoriyasi inyektsiya orqali yuboriladigan yallig'lanishga qarshi davolash vositalarini almashtirish uchun mo'ljallangan xavfsiz tabletkalarning yaratilishiga tayanadi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_IMUX_-_Immunic-Inc._-_PE-Multiple "IMUX: Immunic Inc Biznesning o‘zini qoplash muddati 04.07.2022 - 10.11.2026 | 👁️GURU.Markets👁️")
Immunic Therapeutics (IMUX) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Immunic, Inc.|IMUX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Immunic Inc|IMUX - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Immunic Therapeutics|IMUX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Immunic|Oraliq qoplama koeffitsiyenti immunic-therapeutics.com
- foyda va bozor multiplikatorlari tafsilotlari:
IMUX - Kompaniyaning sof foydasi|Kelajakdagi foyda Immunic, Inc.|IMUX - Narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Immunic Inc|IMUX - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Immunic Therapeutics|IMUX - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun foyda Immunic|IMUX - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi immunic-therapeutics.com|IMUX - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Immunic, Inc.
Kompaniyaning har tomonlama tahlili:immunic-therapeutics.com IMUX
P/E koeffitsiyenti biznesning bozor qiymatini uning yillik sof daromadiga nisbatan belgilaydi va investor kompaniyaning joriy daromadlarining har bir birligi uchun qancha to'lashga tayyorligini ko'rsatadi. P/E multiplikatorini tahlil qilish orqali, Immunic, Inc. (IMUX) kapitalizatsiyasini skleroz terapiyasiga bo'lgan doimiy talab prizmasi orqali baholash mumkin, bu esa emitentga yuqori pul oqimi bashorat qilinuvchanligini va aktivlarning uzoq muddatli barqarorligini kafolatlaydi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|Biznesning o‘zini qoplash muddati Tourmaline TRML|Precigen, Inc. (PGEN) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti pharming.com|Narxning foydaga nisbati Nektar Therapeutics Inc.|Narx-foyda koeffitsiyenti Upstream Bio, Inc. (UPB)|Narx-foyda koeffitsiyenti ZBIO (Zenas Biopharma, Inc.)|P/E multiplikatori Immunome Bio (IMNM)|Narxning foydaga nisbati Gossamer Bio, Inc. GOSS|KALV: Narx-foyda multiplikatori|Septerna - P/E multiplikatori|Biznesning o‘zini qoplash muddati Pieris Pharma PVLA|SVRA: P/E multiplikatori|Narx-foyda koeffitsiyenti Rigel Corp|Narx-foyda koeffitsiyenti ANAB|ATXS: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ENGN|Biznesning o‘zini qoplash muddati RAPT Therapeutics Inc.|Narxning foydaga nisbati Aerovate Therapeutics JBIO|ACRS: Narx-foyda multiplikatori|Kyverna Therapeutics - P/E multiplikatori|tizianalifesciences.com (TLSA) - Narx-foyda koeffitsiyenti|CABA (Cabaletta Bio) - Narx-foyda koeffitsiyenti|VTYX - Biznesning o‘zini qoplash muddati|THTX (Theratechnologies Inc) - P/E multiplikatori|Avalo Therapeutics Inc (AVTX) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Eledon Pharmaceuticals (ELDN)|Narx-foyda koeffitsiyenti agenusbio.com AGEN|Climb Bio - Narx-foyda koeffitsiyenti|P/E multiplikatori Zura Bio Ltd ZURA|ATYR: Narx-foyda koeffitsiyenti|ADAG (Adagene) - Narx-foyda multiplikatori|ikenaoncology.com (IMA) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati STTK (Shattuck Labs)|EQ (Equillium Inc) - P/E multiplikatori|CNTB: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ATRA|P/E multiplikatori inflarx.de (IFRX)|Narxning foydaga nisbati X4 Pharmaceuticals XFOR|Kompaniya qiymatining sof foydaga nisbati ACET|CELU - Narxning foydaga nisbati|INmune Bio Inc (INMB) - Narx-foyda koeffitsiyenti|BRNS: P/E multiplikatori|Kezar Life Sciences Inc (KZR) - P/E multiplikatori|Narx-foyda koeffitsiyenti SABS|AKTX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ENLV|Biznesning o‘zini qoplash muddati q32bio.com|Narxning foydaga nisbati GeoVax Labs Inc GOVX|EDSA - Narx-foyda koeffitsiyenti|IBIO - Narxning foydaga nisbati|Carisma Therapeutics (CARM) - Narx-foyda koeffitsiyenti|XTLB (XTL Biopharmaceuticals Ltd.) - Narx-foyda koeffitsiyenti|Bolt Biotherapeutics, Inc. (BOLT) - P/E multiplikatori|Narxning foydaga nisbati HCW Biologics, Inc.|Narx-foyda multiplikatori APVO (Aptevo)|P/E multiplikatori AIM|ADTX - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori GRI (GRI Bio)|Biznesning o‘zini qoplash muddati XORTX Therapeutics Inc (XRTX)|HIND - Narxning foydaga nisbati|Revelation Biosciences Corp (REVB) - Narx-foyda koeffitsiyenti|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti scinai.com|Narx-foyda koeffitsiyenti CALI|P/E multiplikatori Affimed Therapeutics|Narxning foydaga nisbati Allakos Inc. (ALLK)|hookipapharma.com - Narx-foyda multiplikatori|P/E multiplikatori IGMS (IGM Biosciences)|Biznesning o‘zini qoplash muddati iteostherapeutics.com (ITOS)|Ocean Biomedical - P/E multiplikatori|TC BioPharm (Holdings) Plc (TCBP) - Narx-foyda koeffitsiyenti|THRD (Third Harmonic Bio, Inc) - Narx-foyda koeffitsiyenti
